Area of research
Radiology, Nuclear Medicine and Imaging · Genetics
Research interest
Research interests include Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications, Glioma Diagnosis and Treatment, and Alzheimer's disease research and treatments.
3D printing of radioactive wall-less PET phantoms improves threshold-based target delineation and quantification
Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease
Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET
Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease
[18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET–Based Salvage Radiotherapy for Recurrent Prostate Cancer
Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
Feasibility of radiomic feature harmonization for pooling of [18F]FET or [18F]GE-180 PET images of gliomas
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages
Association of Neurofilament Light Chain, [ <sup>18</sup> F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid–Negative CBS
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma
Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy
Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution
Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease
Tau deposition patterns are associated with functional connectivity in primary tauopathies
TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis
Additive value of [18F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
Longitudinal [18F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model
18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms
S3-Leitlinie: Diagnostik und Therapie biliärer Karzinome
Can Radiomics Provide Additional Information in [18F]FET-Negative Gliomas?
Impact of Partial Volume Correction on [18F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome
Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumors